Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06025357
Status:
RECRUITING
Last Update Posted:
2023-09-06
First Post:
2023-07-27
Brief Title:
Effects of L-citrulline Supplementation on Vascular Function in Metabolic Syndrome
Sponsor:
Texas Tech University
Organization:
Texas Tech University
Study Overview
Official Title:
Effects of L-Citrulline Supplementation on Vascular Function During Fasted and Acute Hyperglycemia in Middle-aged and Older Women With Metabolic Syndrome
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this project is to provide evidence that L-Citrulline CIT supplementation can improve vascular function in the fasted and acute hyperglycemia conditions in middle-aged and older women with metabolic syndrome
Detailed Description:
Using a double-blind randomized placebo-controlled and parallel design middle-aged and older women with metabolic syndrome will be randomized into receiving either CIT supplementation 10gday or placebo Microcrystalline Cellulose for 4 weeks
The first visit will be approximately 1hr and 30 minutes The 2nd and 3rd visits will each be approximately 2hrs and 30 minutes separated by 4 weeks in between each visit During visits 2 and 3 vascular measurements will be assessed in the fasted state and 30 60 and 90 minutes after acute glucose ingestion 75g
The first visit will be approximately 1hr and 30 minutes The 2nd and 3rd visits will each be approximately 2hrs and 30 minutes separated by 4 weeks in between each visit During visits 2 and 3 vascular measurements will be assessed in the fasted state and 30 60 and 90 minutes after acute glucose ingestion 75g
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None